1. Home
  2. GL vs ALGN Comparison

GL vs ALGN Comparison

Compare GL & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

N/A

Current Price

$160.20

Market Cap

12.1B

Sector

Finance

ML Signal

N/A

Logo Align Technology Inc.

ALGN

Align Technology Inc.

N/A

Current Price

$168.98

Market Cap

10.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GL
ALGN
Founded
1900
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
10.5B
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
GL
ALGN
Price
$160.20
$168.98
Analyst Decision
Buy
Buy
Analyst Count
11
16
Target Price
$185.18
★ $185.79
AVG Volume (30 Days)
545.1K
★ 1.1M
Earning Date
10-21-2026
10-28-2026
Dividend Yield
★ 0.82%
N/A
EPS Growth
★ 17.84
0.53
EPS
★ 11.64
4.98
Revenue
★ $5,994,318,000.00
$387,126,000.00
Revenue This Year
$6.55
$2.24
Revenue Next Year
$6.20
$2.86
P/E Ratio
★ $13.77
$33.59
Revenue Growth
3.74
★ 23.95
52 Week Low
$129.21
$130.23
52 Week High
$191.55
$200.44

Technical Indicators

Market Signals
Indicator
GL
ALGN
Relative Strength Index (RSI) 45.24 62.33
Support Level $155.45 $164.75
Resistance Level $166.32 $183.23
Average True Range (ATR) 3.21 6.51
MACD 0.41 1.56
Stochastic Oscillator 52.19 75.56

Price Performance

Historical Comparison
GL
ALGN

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: